![Mark Hahn](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Hahn
Direttore/Membro del Consiglio presso
ALSP ORCHID ACQUISITION CORPORATION I
Profilo
Mark W.
Hahn is an Independent Director at ALSP Orchid Acquisition Corp.
I since 2021.
Mr. Hahn is a Director at Opterion Health AG.
Former roles include Independent Director at Soleno Therapeutics, Inc. from 2025 to 2026; Chief Financial Officer at Charles & Colvard Ltd. from 1984 to 1996; Chief Financial Officer, Secretary & Treasurer at Verona Pharma Ltd.; Chief Financial Officer at Equitel, Inc.; Principal at Ernst & Young LLP; Chief Financial Officer at Athenix Corp.
from 2008 to 2009; Chief Financial Officer & VP-Administration at Gigabeam Corp.
from 2007 to 2008; Chief Financial Officer at BuildLinks, Inc. from 2002 to 2007; Chief Financial Officer & Executive Vice President at Cempra Pharmaceuticals, Inc. and Cempra, Inc. from 2010 to 2017; Chief Financial Officer at Performaworks, Inc.; and Chief Financial Officer at Dova Pharmaceuticals, Inc. from 2018 to 2019.
Education includes an undergraduate degree from the University of Wisconsin-Milwaukee conferred in 1984.
Posizioni attive di Mark Hahn
| Società | Posizione | Inizio |
|---|---|---|
| ALSP ORCHID ACQUISITION CORPORATION I | Direttore/Membro del Consiglio | 01/11/2021 |
Opterion Health AG
 Opterion Health AG Medical/Nursing ServicesHealth Services Provides chronic kidney disease services | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Mark Hahn
| Società | Posizione | Fine |
|---|---|---|
| SOLENO THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 15/05/2026 |
| DOVA PHARMACEUTICALS, INC. | Direttore Finanziario/CFO | 12/11/2019 |
Cempra Pharmaceuticals, Inc.
 Cempra Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops medicines for treating drug-resistant bacterial infections | Direttore Finanziario/CFO | 30/11/2017 |
Cempra, Inc.
 Cempra, Inc. Pharmaceuticals: MajorHealth Technology Operates as a holding company with interest in manufacturing pharmaceutical products | Direttore Finanziario/CFO | 01/11/2017 |
Athenix Corp.
 Athenix Corp. Chemicals: AgriculturalProcess Industries Develops agricultural herbicide tolerance and insect control chemicals | Direttore Finanziario/CFO | 01/01/2009 |
Formazione di Mark Hahn
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
50
Relazioni di 1° grado
15
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 15 |
|---|---|
Charles & Colvard Ltd.
 Charles & Colvard Ltd. Other Consumer SpecialtiesConsumer Durables Manufactures, markets, distributes and sells moissanite jewels | Consumer Durables |
Equitel, Inc.
 Equitel, Inc. Specialty TelecommunicationsCommunications Provides prepaid local telephone and cellular phone service | Communications |
Ernst & Young LLP
 Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Commercial Services |
Athenix Corp.
Athenix Corp. Chemicals: AgriculturalProcess Industries Develops agricultural herbicide tolerance and insect control chemicals | Process Industries |
Gigabeam Corp.
 Gigabeam Corp. Wireless TelecommunicationsCommunications Provides wireless communication solutions | Communications |
BuildLinks, Inc.
 BuildLinks, Inc. Packaged SoftwareTechnology Services Develops construction management and scheduling software for home builders | Technology Services |
Cempra Pharmaceuticals, Inc.
Cempra Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops medicines for treating drug-resistant bacterial infections | Health Technology |
Soleno Therapeutics, Inc.
 Soleno Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and commercializes novel therapeutics for the treatment of rare diseases | Health Technology |
Cempra, Inc.
Cempra, Inc. Pharmaceuticals: MajorHealth Technology Operates as a holding company with interest in manufacturing pharmaceutical products | Health Technology |
Performaworks, Inc.
 Performaworks, Inc. Packaged SoftwareTechnology Services Provides data processing services | Technology Services |
Verona Pharma Plc
 Verona Pharma Plc Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of allergic rhinitis and other chronic respiratory diseases | Health Technology |
University of Wisconsin-Milwaukee
 University of Wisconsin-Milwaukee Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Dova Pharmaceuticals, Inc.
 Dova Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes drugs with disorder of low blood platelet count | Health Technology |
Opterion Health AG
Opterion Health AG Medical/Nursing ServicesHealth Services Provides chronic kidney disease services | Health Services |
ALSP Orchid Acquisition Corp. I
 ALSP Orchid Acquisition Corp. I Financial ConglomeratesFinance Operates as a blank check company | Finance |
